Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
Kymera Therapeutics, Inc. (KYMR)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
SELL
1 Mar 2024
Jacobs Bruce N.
Chief Financial Officer, Officer
Kymera Therapeutics, Inc.
(KYMR)
143,907
-2%
3,934
$41.86
$164,664.19
SELL
1 Mar 2024
Gollob Jared
Chief Medical Officer, Officer
Kymera Therapeutics, Inc.
(KYMR)
97,062
-3%
3,344
$41.86
$139,967.47
SELL
27 Feb 2024
Gollob Jared
Chief Medical Officer, Officer
Kymera Therapeutics, Inc.
(KYMR)
74,709
-0%
400
$45.00
$18,000.00
SELL
20 Feb 2024
Albers Jeffrey W.
Director
Kymera Therapeutics, Inc.
(KYMR)
0
-100%
5,000
$39.05
$195,257.67
SELL
9 Feb 2024
Gollob Jared
Chief Medical Officer, Officer
Kymera Therapeutics, Inc.
(KYMR)
82,107
-35%
46,137
$35.50
$1,638,071.50
SELL
23 Jan 2024
Albers Jeffrey W.
Director
Kymera Therapeutics, Inc.
(KYMR)
0
-100%
10,000
$30.05
$300,470.00
SELL
4 Jan 2024
Chiniara Ellen
Chief Legal Officer, Officer
Kymera Therapeutics, Inc.
(KYMR)
34,205
-8%
3,295
$22.58
$74,415.60
BUY
2 Nov 2023
BVF PARTNERS L P/IL
Director, See Remarks and Footnotes
Kymera Therapeutics, Inc.
(KYMR)
2,656,191
+18%
414,105
$12.80
$5,301,325.50
SELL
1 Mar 2023
Jacobs Bruce N.
Chief Financial Officer, Officer
Kymera Therapeutics, Inc.
(KYMR)
104,882
-1%
1,370
$31.00
$42,465.29
SELL
1 Mar 2023
Caughey Elaine
Chief Business Officer, Officer
Kymera Therapeutics, Inc.
(KYMR)
19,150
-3%
714
$31.00
$22,131.73
SELL
11 Jan 2023
Atlas Venture Fund X, L.P.
10% Owner
Kymera Therapeutics, Inc.
(KYMR)
4,968,114
-2%
126,474
$30.22
$3,821,738.80
SELL
11 Jan 2023
Booth Bruce
Director
Kymera Therapeutics, Inc.
(KYMR)
4,968,114
-2%
126,474
$30.22
$3,821,738.80
BUY
11 Jan 2023
BVF PARTNERS L P/IL
Director, See Remarks and Footnotes
Kymera Therapeutics, Inc.
(KYMR)
2,494,688
+1%
41,007
$30.51
$1,251,190.80
SELL
14 Dec 2022
Atlas Venture Fund X, L.P.
10% Owner
Kymera Therapeutics, Inc.
(KYMR)
5,066,925
-7%
382,244
$31.36
$11,985,955.00
SELL
14 Dec 2022
Booth Bruce
Director
Kymera Therapeutics, Inc.
(KYMR)
5,066,925
-7%
382,244
$31.36
$11,985,955.00
SELL
2 Nov 2022
Atlas Venture Fund X, L.P.
10% Owner
Kymera Therapeutics, Inc.
(KYMR)
5,365,563
-3%
220,016
$30.01
$6,602,952.50
SELL
2 Nov 2022
Booth Bruce
Director
Kymera Therapeutics, Inc.
(KYMR)
5,365,563
-3%
220,016
$30.01
$6,602,952.50
SELL
28 Oct 2022
Atlas Venture Fund X, L.P.
10% Owner
Kymera Therapeutics, Inc.
(KYMR)
5,541,183
-4%
288,702
$30.26
$8,735,144.00
SELL
28 Oct 2022
Booth Bruce
Director
Kymera Therapeutics, Inc.
(KYMR)
5,541,183
-4%
288,702
$30.26
$8,735,144.00
BUY
22 Aug 2022
BVF PARTNERS L P/IL
Director, See Remarks and Footnotes
Kymera Therapeutics, Inc.
(KYMR)
2,480,742
+28%
545,525
$26.00
$14,183,650.00
BUY
26 May 2022
BVF PARTNERS L P/IL
Director, See Remarks and Footnotes
Kymera Therapeutics, Inc.
(KYMR)
2,195,696
+15%
289,426
$14.34
$4,150,321.20
BUY
20 May 2022
BVF PARTNERS L P/IL
Director, See Remarks and Footnotes
Kymera Therapeutics, Inc.
(KYMR)
2,036,860
+0%
10,100
$14.00
$141,393.95
BUY
5 May 2022
BVF PARTNERS L P/IL
Director, See Remarks and Footnotes
Kymera Therapeutics, Inc.
(KYMR)
2,030,977
+14%
250,000
$19.46
$4,865,365.00
BUY
27 Jan 2022
BVF PARTNERS L P/IL
Director, See Remarks
Kymera Therapeutics, Inc.
(KYMR)
1,900,272
+7%
130,309
$38.96
$5,076,473.00
BUY
24 Jan 2022
BVF PARTNERS L P/IL
Director, See Remarks
Kymera Therapeutics, Inc.
(KYMR)
1,822,145
+17%
272,767
$37.76
$10,300,637.00
SELL
12 Jan 2022
Jacobs Bruce N.
Chief Financial Officer, Officer
Kymera Therapeutics, Inc.
(KYMR)
26,087
-36%
15,000
$51.85
$777,684.06
SELL
10 Jan 2022
Mainolfi Nello
Chief Executive Officer, Director, Officer
Kymera Therapeutics, Inc.
(KYMR)
478,085
-9%
48,000
$53.31
$2,558,742.20
SELL
3 Dec 2021
Jacobs Bruce N.
Chief Financial Officer, Officer
Kymera Therapeutics, Inc.
(KYMR)
19,801
-33%
10,000
$53.56
$535,637.00
SELL
1 Nov 2021
Gollob Jared
Chief Medical Officer, Officer
Kymera Therapeutics, Inc.
(KYMR)
31,139
-64%
57,493
$62.16
$3,573,658.00
SELL
8 Oct 2021
Mainolfi Nello
Chief Executive Officer, Director, Officer
Kymera Therapeutics, Inc.
(KYMR)
464,943
-9%
48,000
$56.34
$2,704,536.00
SELL
3 Sep 2021
Jacobs Bruce N.
Chief Financial Officer, Officer
Kymera Therapeutics, Inc.
(KYMR)
8,756
-53%
10,000
$60.12
$601,180.06
SELL
27 Aug 2021
Chesworth Richard
Chief Scientific Officer, Officer
Kymera Therapeutics, Inc.
(KYMR)
0
-100%
33,779
$60.12
$2,030,864.50
SELL
17 Aug 2021
Chesworth Richard
Chief Scientific Officer, Officer
Kymera Therapeutics, Inc.
(KYMR)
45,191
-54%
54,000
$50.37
$2,720,181.80
SELL
11 Aug 2021
ATLAS VENTURE ASSOCIATES X, L.P.
10% Owner
Kymera Therapeutics, Inc.
(KYMR)
0
-100%
242,133
$61.00
$14,770,113.00
SELL
11 Aug 2021
Booth Bruce
Director
Kymera Therapeutics, Inc.
(KYMR)
0
-100%
242,133
$61.00
$14,770,113.00
SELL
3 Aug 2021
Mainolfi Nello
Chief Executive Officer, Director, Officer
Kymera Therapeutics, Inc.
(KYMR)
452,199
-1%
6,706
$60.06
$402,786.30
SELL
29 Jul 2021
Mainolfi Nello
Chief Executive Officer, Director, Officer
Kymera Therapeutics, Inc.
(KYMR)
454,023
-6%
30,415
$60.25
$1,832,370.80
SELL
26 Jul 2021
Mainolfi Nello
Chief Executive Officer, Director, Officer
Kymera Therapeutics, Inc.
(KYMR)
452,199
-2%
12,879
$60.15
$774,646.50
SELL
8 Jul 2021
Mainolfi Nello
Chief Executive Officer, Director, Officer
Kymera Therapeutics, Inc.
(KYMR)
482,969
-9%
48,000
$49.70
$2,385,628.50
BUY
1 Jul 2021
BVF PARTNERS L P/IL
Director, See Remarks
Kymera Therapeutics, Inc.
(KYMR)
1,664,104
+48%
544,166
$47.00
$25,575,802.00
SELL
10 Jun 2021
Mainolfi Nello
Chief Executive Officer, Director, Officer
Kymera Therapeutics, Inc.
(KYMR)
425,105
-5%
23,009
$51.38
$1,182,106.10
SELL
7 Jun 2021
Mainolfi Nello
Chief Executive Officer, Director, Officer
Kymera Therapeutics, Inc.
(KYMR)
412,199
-4%
18,746
$50.10
$939,261.25
SELL
3 Jun 2021
Jacobs Bruce N.
Chief Financial Officer, Officer
Kymera Therapeutics, Inc.
(KYMR)
11,494
-46%
10,000
$46.87
$468,695.10
SELL
12 May 2021
Mainolfi Nello
Chief Executive Officer, Director, Officer
Kymera Therapeutics, Inc.
(KYMR)
397,199
-2%
8,245
$50.05
$412,677.10
SELL
22 Apr 2021
Mainolfi Nello
Chief Executive Officer, Director, Officer
Kymera Therapeutics, Inc.
(KYMR)
397,199
-3%
14,407
$40.23
$579,618.50
SELL
15 Apr 2021
Mainolfi Nello
Chief Executive Officer, Director, Officer
Kymera Therapeutics, Inc.
(KYMR)
391,199
-1%
5,593
$40.26
$225,159.17
SELL
8 Apr 2021
Mainolfi Nello
Chief Executive Officer, Director, Officer
Kymera Therapeutics, Inc.
(KYMR)
381,104
-11%
48,000
$33.62
$1,613,563.00
SELL
12 Mar 2021
ATLAS VENTURE ASSOCIATES X, L.P.
10% Owner
Kymera Therapeutics, Inc.
(KYMR)
0
-100%
229,350
$56.50
$12,958,275.00
SELL
12 Mar 2021
Booth Bruce
Director
Kymera Therapeutics, Inc.
(KYMR)
0
-100%
229,350
$56.50
$12,958,275.00
SELL
11 Mar 2021
Jacobs Bruce N.
Chief Financial Officer, Officer
Kymera Therapeutics, Inc.
(KYMR)
0
-100%
10,000
$60.15
$601,527.56
SELL
11 Mar 2021
Gollob Jared
Chief Medical Officer, Officer
Kymera Therapeutics, Inc.
(KYMR)
42,547
-26%
15,000
$60.13
$901,990.75
SELL
8 Mar 2021
Jacobs Bruce N.
Chief Financial Officer, Officer
Kymera Therapeutics, Inc.
(KYMR)
2,301
-81%
10,000
$50.65
$506,470.10
SELL
3 Mar 2021
Jacobs Bruce N.
Chief Financial Officer, Officer
Kymera Therapeutics, Inc.
(KYMR)
13,119
-60%
20,000
$44.78
$895,633.80
SELL
22 Feb 2021
Gollob Jared
Chief Medical Officer, Officer
Kymera Therapeutics, Inc.
(KYMR)
47,547
-43%
37,064
$50.68
$1,878,355.20
SELL
17 Feb 2021
Gollob Jared
Chief Medical Officer, Officer
Kymera Therapeutics, Inc.
(KYMR)
84,611
-21%
22,936
$56.42
$1,293,935.80
Home